{
  "meta": {
    "title": "Basics_Of_Immune_System_Activation",
    "url": "https://brainandscalpel.vercel.app/basics-of-immune-system-activation-6713df47.html",
    "scrapedAt": "2025-11-29T18:32:09.701Z"
  },
  "questions": [
    {
      "id": 14146,
      "choices": [
        {
          "id": 56545,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antigen Specific Receptors </span></span></span></p>"
        },
        {
          "id": 56546,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class I MHC Expression </span></span></span></p>"
        },
        {
          "id": 56547,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive selection during development </span></span></span></p>"
        },
        {
          "id": 56548,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the process of lymphocyte development, which of the following processes occurs in T cells but not in B cells?</span></span></span></p>",
      "unique_key": "Q6833227",
      "question_audio": null,
      "question_video": null,
      "map_id": 31842,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Positive selection during development</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive Selection during Development:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Positive selection ensures that developing<strong> T cells in the thymus cortex </strong>have <strong>TCRs </strong>that can appropriately recognize<strong> self-MHC molecules</strong>. This process<strong> does not occur in B cells; </strong>their selection processes, including &quot;receptor editing&quot; for self-reactivity, occur in the bone marrow and peripheral lymphoid organs.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Antigen-Specific Receptors:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Both<strong> B cells and T cells </strong>develop <strong>antigen-specific receptors. </strong>B cells produce a <strong>membrane-bound form of antibody </strong>as their <strong>antigen-specific receptor</strong>, while <strong>T cells develop T-cell receptors (TCRs).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Class I MHC Expression:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Both<strong> B cells and T cells express Class I MHC molecules. </strong>These are present on nearly all <strong>nucleated cells in the body </strong>and are important for presenting <strong>endogenous antigens to CD8+ cytotoxic T cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: All of the Above:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Since only positive selection is unique to T cells, this option is<strong> not correct.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive selection during development, which ensures that<strong> T cells have T-cell receptors capable of recognizing self-MHC molecules,</strong> occurs in <strong>T cells</strong> but <strong>not in B cells.</strong> Understanding the <strong>unique and shared aspects of T and B cell development</strong> is important for recognizing how <strong>different immune deficiencies </strong>can affect the <strong>immune system&#39;s function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Immunology by SK Gupta 1st/142-150, Robbins 10<sup>th</sup> 194-6, 216)</span></span></strong></p>",
      "correct_choice_id": 56547,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14181,
      "choices": [
        {
          "id": 56685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area postrema </span></span></span></p>"
        },
        {
          "id": 56686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loop of Henle </span></span></span></p>"
        },
        {
          "id": 56687,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Optic nerve </span></span></span></p>"
        },
        {
          "id": 56688,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seminiferous tubules </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anatomical locations is considered an immune-privileged site, where immune responses are typically reduced to prevent potential damage from inflammation?</span></span></span></p>",
      "unique_key": "Q2342024",
      "question_audio": null,
      "question_video": null,
      "map_id": 31853,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Seminiferous tubules </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>testis, eye, and brain, </strong>all of which are called <strong>immune privileged sites </strong>because it is difficult to<strong> induce immune responses </strong>to <strong>antigens </strong>introduced into these sites. If the<strong> antigens of these tissues </strong>are released, for example, as a <strong>consequence of trauma or infection</strong>, the result may be an <strong>immune response </strong>that leads to <strong>prolonged tissue inflam&shy;mation and injury</strong>. This is the postulated mechanism for<strong> post-traumatic orchitis and uveitis. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seminiferous tubules:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The seminiferous tubules, located within the<strong> testis, </strong>are indeed an <strong>immune-privileged </strong>site to protect <strong>spermatogenic cells </strong>from<strong> autoimmune responses</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Area postrema:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The area postrema is a structure in the brain that<strong> controls vomiting in response to toxins</strong>, but it is not traditionally considered an immune-privileged site.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Loop of Henle:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Loop of Henle is part of the <strong>nephron in the kidney </strong>involved in the <strong>concentration of urine </strong>and is <strong>not an immune-privileged site</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Optic nerve:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While the optic nerve is part of the<strong> central nervous system (CNS), </strong>which is considered <strong>immune-privileged</strong>, the term typically refers to the <strong>eye as a whole </strong>rather than individual structures<strong> within it</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Immune-privileged </strong>sites such as the<strong> seminiferous tubules, eyes, and brain </strong>are areas where<strong> immune responses are specifically downregulated </strong>to prevent damage that can occur from<strong> inflammation</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 214)</span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><em> </em></span></strong></span></span></p>",
      "correct_choice_id": 56688,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14149,
      "choices": [
        {
          "id": 56557,
          "text": "<p><span style=\"font-size:12pt;\">Binds to B7 and CD28 co-stimulatory molecules</span></p>"
        },
        {
          "id": 56558,
          "text": "<p><span style=\"font-size:12pt;\">Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation</span></p>"
        },
        {
          "id": 56559,
          "text": "<p><span style=\"font-size:12pt;\">Binds to the CD4 + molecule causing T cell activation</span></p>"
        },
        {
          "id": 56560,
          "text": "<p><span style=\"font-size:12pt;\">Is presented by macrophages to a larger-than-normal number of T helper CD4 + lymphocytes</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">During a hospital outbreak of a severe systemic inflammatory response syndrome, an infectious disease consultant suggests the possibility of superantigen involvement. Which of the following mechanisms best l the action of bacterial superantigens in the context of this condition?</span></p>",
      "unique_key": "Q3255044",
      "question_audio": null,
      "question_video": null,
      "map_id": 31845,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation:</strong> Superantigens bridge the <strong>TCR on T cells and MHC class II on antigen-presenting cells outside the conventional peptide-binding groove</strong>, leading to widespread <strong>T cell activation </strong>without the need for <strong>specific antigen recognition.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Binds to B7 and CD28 co-stimulatory molecules:</strong> These molecules are involved in the <strong>second signal required for T cell activation. </strong>However, superantigens do not typically bind to these molecules directly.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Binds to the CD4+ molecule causing T cell activation:</strong> While CD4+ is a <strong>co-receptor for TCRs on helper T cells, superantigens </strong>do<strong> not</strong> primarily function by <strong>binding to CD4+ molecules. </strong>They act more broadly to <strong>cross-link TCRs and MHC class II molecules.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Is presented by macrophages to a larger-than-normal number of T helper CD4+ lymphocytes:</strong> Superantigens do not get presented in the conventional sense as <strong>peptides by APCs</strong>. Instead, they interact with<strong> TCRs and MHC class II molecules to non-specifically </strong>activate a large number of<strong> T cells.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Superantigens </strong>are bacterial products that can cause a <strong>massive T cell response </strong>by binding to the beta chain of<strong> TCRs and MHC class II molecules on APCs</strong>, leading to the <strong>non-specific activation of T cells. </strong>Some examples include <strong>toxic shock syndrome toxin-1 (TSST-1 produced in a female using unhygienic sanitory tampons), Streptococcal pyrogenic exotoxins (SPE), Staphylococcal enterotoxins (SE), and enterotoxogenic E. coli (ETEC) enterotoxin.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/picture2.jpg\" alt=\"\" width=\"700\" height=\"529\"></span></p>",
      "correct_choice_id": 56558,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14140,
      "choices": [
        {
          "id": 56521,
          "text": "<p><span style=\"font-size:12pt;\">NOD like receptor</span></p>"
        },
        {
          "id": 56522,
          "text": "<p><span style=\"font-size:12pt;\">GPCR</span></p>"
        },
        {
          "id": 56523,
          "text": "<p><span style=\"font-size:12pt;\">C type of lectin receptor</span></p>"
        },
        {
          "id": 56524,
          "text": "<p><span style=\"font-size:12pt;\">Toll like receptor</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 55-year-old male with a history of hypertension presents with a sudden onset of severe pain, redness, and swelling in the big toe. His serum uric acid levels are elevated. Which pattern recognition receptor is most likely involved in the inflammatory response seen in this patient's condition?</span></p>",
      "unique_key": "Q2556036",
      "question_audio": null,
      "question_video": null,
      "map_id": 31837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) NOD like receptor</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">NOD like receptor is useful for detection of danger associated molecular patterns like <strong>uric acid, cholesterol, K+ efflux and depletion of ATP</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>NOD-like Receptor (NLR)</strong> NOD-like receptors are <strong>intracellular sensors of the innate immune system </strong>that detect <strong>danger-associated molecular patterns (DAMPs) </strong>and<strong> pathogen-associated molecular patterns (PAMPs). </strong>They are implicated in the inflammatory response to <strong>uric acid crystals in gout</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: G Protein-Coupled Receptor (GPCR):</strong> GPCRs are a<strong> large protein family </strong>of receptors that sense molecules<strong> outside the cell and activate internal signal transduction pathways </strong>and, ultimately, cellular responses. They are not primarily known for recognizing uric acid crystals.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: C-type Lectin Receptor (CLR):</strong> C-type lectin receptors are a <strong>class of pattern recognition receptors </strong>that are key players in the immune system,<strong> recognizing fungal pathogens </strong>and playing a role in<strong> antifungal immunity. </strong>They are not directly involved in the recognition of uric acid crystals.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Toll-like Receptor (TLR):</strong> Toll-like receptors are a <strong>class of proteins </strong>that play a key role in the <strong>innate immune system</strong>. They recognize structurally conserved molecules derived from <strong>microbes and are important in the initial immune response, </strong>not specifically in the recognition of uric acid crystals associated with gout.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>NOD-like receptors (NLRs) </strong>are involved in the detection of<strong> danger-associated molecular patterns </strong>such as<strong> uric acid, </strong>which is relevant in the pathogenesis of gout.</span></p>",
      "correct_choice_id": 56521,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14143,
      "choices": [
        {
          "id": 56533,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha defensins</span></span></span></p>"
        },
        {
          "id": 56534,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B lymphocytes</span></span></span></p>"
        },
        {
          "id": 56535,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delta gamma T lymphocytes</span></span></span></p>"
        },
        {
          "id": 56536,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lectin pathway</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with a suspected immune deficiency, various components of the immune system are being assessed to identify the potential defect. Which of the following immune components is primarily associated with adaptive immunity rather than innate immunity?</span></span></span></p>",
      "unique_key": "Q5524943",
      "question_audio": null,
      "question_video": null,
      "map_id": 31840,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) B lymphocytes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B Lymphocytes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> B lymphocytes, or B cells, are central to<strong> adaptive immunity</strong>. They are responsible for the production of antibodies in response to <strong>specific antigens</strong>, a process that involves<strong> clonal selection and memory cell formation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Alpha Defensins:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Alpha defensins are<strong> antimicrobial peptides </strong>produced by<strong> Paneth cells in the intestines</strong>. They play a crucial role in the <strong>innate immune </strong>response by directly killing <strong>microbes and contribute to the innate defense of mucosal surfaces.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Delta Gamma T Lymphocytes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Delta gamma T cells (&gamma;&delta; T cells) are a<strong> subset of T cells </strong>that have T cell receptors different from the classic <strong>&alpha;&beta; T cell receptors. </strong>These cells can respond to certain antigens <strong>without </strong>the need for <strong>antigen processing and presentation by MHC molecules</strong>, bridging<strong> innate and adaptive immunity</strong>. They are often considered a part of the innate immune system due to their<strong> rapid response and lack of requirement for specific antigen presentation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Lectin Pathway:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The lectin pathway is part of the <strong>complement system</strong>, which is a key component of the innate immune system. It involves the binding of<strong> mannose-binding lectin to pathogens</strong>, leading to their <strong>opsonization and subsequent phagocytosis or lysis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B lymphocytes </strong>are part of the<strong> adaptive immune system </strong>and are responsible for<strong> humoral immunity </strong>through the <strong>production of antibodies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p195)</span></strong></span></span></p>",
      "correct_choice_id": 56534,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14147,
      "choices": [
        {
          "id": 56549,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alfa and Beta chain </span></span></span></p>"
        },
        {
          "id": 56550,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Distal domain alfa 1 and 2 </span></span></span></p>"
        },
        {
          "id": 56551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alfa and beta microglobulin </span></span></span></p>"
        },
        {
          "id": 56552,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proximal domain alfa 1 and 2 </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is studying the structure of MHC molecules and their role in antigen presentation. When considering MHC class I molecules and their interaction with T cells, which structural component of the MHC class I molecule is responsible for forming the peptide-binding cleft?</span></span></span></p>",
      "unique_key": "Q9215139",
      "question_audio": null,
      "question_video": null,
      "map_id": 31843,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Distal domain alfa 1 and 2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Distal domain alpha 1 and 2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>peptide-binding cleft of MHC class I molecules </strong>is formed by the<strong> distal domains of the alpha 1 and alpha 2 chains. </strong>This is where <strong>peptides bind for presentation to CD8+ cytotoxic T cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Alpha and Beta chain:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>MHC class II molecule </strong>consists of two separate protein chains,<strong> alpha and beta</strong>, each contributing to the formation of the<strong> antigen-binding cleft</strong>. This option is <strong>not accurate for MHC class I molecules</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Alpha and Beta2-microglobulin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Beta 2-microglobulin is a component of the<strong> MHC class I molecule </strong>but <strong>does not form part of the antigen-binding cleft</strong>. Instead, it supports the structure of the<strong> MHC class I molecule.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Proximal domain alpha 1 and 2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The proximal domains of MHC molecules are<strong> not involved in peptide binding</strong>; they are closer to the membrane and play a role in maintaining the <strong>structure of the molecule on the cell surface.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> peptide-binding cleft of MHC class I molecules </strong>is formed by the <strong>distal domains of the alpha 1 and alpha 2 chains </strong>whereas <strong>peptide-binding cleft of MHC class II molecules </strong>is formed by the <strong>distal domains of the alpha 1 and beta 1 chains</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 195)</span></span></strong></p>",
      "correct_choice_id": 56550,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14158,
      "choices": [
        {
          "id": 56593,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC III </span></span></span></p>"
        },
        {
          "id": 56594,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC class I </span></span></span></p>"
        },
        {
          "id": 56595,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC class II </span></span></span></p>"
        },
        {
          "id": 56596,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Any of the above </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old male presents with fever, fatigue, and abdominal pain. Laboratory tests reveal elevated liver enzymes and positive serology for hepatitis B virus. Which of the following molecules is involved in presenting viral peptides to cytotoxic T cells? </span></span></span></p>",
      "unique_key": "Q9813654",
      "question_audio": null,
      "question_video": null,
      "map_id": 31847,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) MHC class I </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC class I molecules</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are responsible for presenting<strong> endogenous peptides</strong>, including <strong><em>viral peptides, to cytotoxic T cells</em></strong>. In this case, the patient&#39;s immune system is likely <strong>mounting a cytotoxic T cell response </strong>against the<strong> hepatitis B virus</strong>, which is causing <strong>liver inflammation and elevated liver enzymes</strong>.<strong> CD4 and CD8 </strong>are <strong>co-receptors </strong>expressed on T cells that interact with<strong> MHC molecules</strong>, but they are <strong>not </strong>directly involved in <strong>peptide presentation. MHC class II molecules </strong>are involved in <strong>presenting exogenous peptides to helper T cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC Class I:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> MHC class I molecules present <strong>endogenous peptides</strong>, including <strong>viral antigens, to cytotoxic T cells</strong>. All <strong>nucleated cells express MHC class I</strong>, which is critical for<strong> immune surveillance and the detection of intracellular pathogens like viruses</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: MHC Class III:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> There is<strong> no MHC class III involved in antigen presentation to T cells</strong>. MHC class III genes encode components of the <strong>complement system and some inflammatory cytokines</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: MHC Class II:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> MHC class II molecules present <strong>exogenous antigens to helper T cells (CD4+ T cells). </strong>These are typically expressed by <strong>professional antigen-presenting cells </strong>such as <strong>dendritic cells, macrophages, and B cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MHC class I</strong>, which presents <strong>endogenous viral peptides to cytotoxic T cells</strong>, initiates a <strong>cellular immune response </strong>essential for the control of<strong> viral infections such as hepatitis B</strong>. </span></span></span></p>",
      "correct_choice_id": 56594,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14167,
      "choices": [
        {
          "id": 56629,
          "text": "<p><span style=\"font-size:12pt;\">Infections</span></p>"
        },
        {
          "id": 56630,
          "text": "<p><span style=\"font-size:12pt;\">Expression of cryptic antigens</span></p>"
        },
        {
          "id": 56631,
          "text": "<p><span style=\"font-size:12pt;\">Negative selective of autoreactive T cells in thymus</span></p>"
        },
        {
          "id": 56632,
          "text": "<p><span style=\"font-size:12pt;\">Receptor editing of T cells</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In a patient presenting with signs and symptoms suggestive of an autoimmune disorder, which of the following mechanisms is most likely to contribute to the prevention, rather than the development, of autoimmunity?</span></p>",
      "unique_key": "Q3783514",
      "question_audio": null,
      "question_video": null,
      "map_id": 31849,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Negative selective of autoreactive T cells in thymus</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Negative selection of autoreactive T cells is a defense mechanism to <strong>reduce the chances of autoimmune disorders</strong>. It is achieved through the process of<strong> apoptosis</strong>.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Negative Selection of T cells in the Thymus:</strong> Negative selection in the<strong> thymus </strong>eliminates T cells that have <strong>high affinity for self-antigens</strong>, thus serving as a central tolerance mechanism to <strong>reduce the risk of autoimmunity.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Infections:</strong> Infections can sometimes<strong> trigger autoimmunity </strong>through mechanisms such as<strong> molecular mimicry</strong>, where an <strong>immune response to an infectious agent cross-reacts with self-antigens.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Expression of Cryptic Antigens:</strong> Cryptic antigens are <strong>self-antigens </strong>that are normally <strong>not visible to the immune system </strong>but can cause an<strong> autoimmune response </strong>when exposed due to<strong> tissue damage or other processes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Receptor Editing of T cells:</strong> Receptor editing refers to the <strong>alteration of B cell receptors on immature B cells </strong>in the bone marrow. If an immature B cell has a<strong> receptor that binds to self-antigens</strong>, the cell can edit its receptor to avoid <strong>self-reactivity</strong>. However, failures in this process can contribute to autoimmunity.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">The phenomenon of receptor editing is not applicable to T cells</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Negative selection of &nbsp;autoreactive T cells in the thymus, </strong>which involves the <strong>apoptosis of T cells </strong>that react strongly to <strong>self-antigens</strong>, is a defence mechanism against<strong> autoimmunity, </strong>not a contributing factor to it. This central tolerance mechanism is crucial for preventing the development of autoimmune diseases.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Reference Robbins 10<sup>th</sup>/218-220</strong></span></p>",
      "correct_choice_id": 56631,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13667,
      "choices": [
        {
          "id": 54629,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of PD1 receptor on T-cells </span></span></span></span></p>"
        },
        {
          "id": 54630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upregulation of expression of PDL1 </span></span></span></span></p>"
        },
        {
          "id": 54631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Induction of galectin</span></span></span></span></p>"
        },
        {
          "id": 54632,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Induction of regulatory T-cells</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following mechanisms does not lead to immune evasion by the tumor cells?</span></span></p>",
      "unique_key": "Q1562625",
      "question_audio": null,
      "question_video": null,
      "map_id": 31852,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Inhibition of PD1 receptor on T-cells</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of<strong> PD-1 receptor (Programmed death -1 receptor) </strong>on T cells causes activation of<strong> immunity against the tumor cells</strong>, not evasion.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PD-1 receptors present on T cells inhibit T-cell activation. </strong>This allows tumors to <strong>evade the host immunity </strong>by the <strong>upregulation </strong>of the expression of factors like <strong>PD-L1 and PD-L2, which act on PD-1 receptors.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibiting the PD1 receptor on T cells </strong>actually leads to the <strong>activation of the immune response against tumor cells.</strong> This is the basis for some of the <strong>cancer immunotherapies,</strong> which <strong>block PD1 </strong>to prevent the<strong> tumor cells </strong>from <strong>evading the immune system.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Upregulation of expression of PDL1:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumor cells often upregulate PD-L1, </strong>which binds to the <strong>PD1 receptor on T cells,</strong> leading to the<strong> inhibition of the immune response</strong> against the<strong> tumor,</strong> effectively allowing the <strong>tumor to evade the immune system.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Induction of galectin&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor cells can induce <strong>galectins,</strong> which are<strong> beta-galactoside-binding proteins</strong> that can <strong>negatively regulate T-cell apoptosis</strong>, affect<strong> T-cell receptor signaling, </strong>or contribute to the creation of an<strong> immunosuppressive tumor microenvironment, facilitating immune evasion</strong>.</span></span></span></span></p>\r\n\r\n<p>;<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Induction of regulatory T-cells:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumors </strong>may induce <strong>regulatory T cells (Tregs), </strong>which suppress the activation of the immune system and maintain<strong> tolerance to self-antigens, </strong>thus aiding in <strong>tumor immune evasion.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibition of the PD1 receptor on T cells does not </strong>lead to <strong>immune evasion</strong> by tumor cells; rather, it <strong>activates the immune response</strong> against the <strong>tumor. PD1 receptor</strong> inhibition is a strategy used in <strong>cancer immunotherapy</strong> to overcome <strong>tumor-induced immune</strong> <strong>suppression.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 312</span></span></strong></span></span></p>",
      "correct_choice_id": 54629,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14135,
      "choices": [
        {
          "id": 56501,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor necrosis factor-alpha (TNF-&alpha;) </span></span></span></p>"
        },
        {
          "id": 56502,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interleukin-6 (IL-6) </span></span></span></p>"
        },
        {
          "id": 56503,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interleukin-1 beta (IL-1</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;</span><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">) </span></span></span></p>"
        },
        {
          "id": 56504,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interleukin-10 (IL-10)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female presents with joint pain, stiffness, and swelling in her hands and wrists. She reports a history of psoriasis and has been diagnosed with psoriatic arthritis. Which cytokine is most likely involved in the pathogenesis of her disease?</span></span></p>",
      "unique_key": "Q8133223",
      "question_audio": null,
      "question_video": null,
      "map_id": 31836,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Tumor necrosis factor-alpha (TNF-&alpha;)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumor necrosis factor-alpha (TNF-&alpha;). </strong>TNF-&alpha; is a<strong> pro-inflammatory cytokine </strong>that plays a key role in the<strong> pathogenesis of psoriatic arthritis. </strong>It is produced by <strong>immune cells, including macrophages and T cells, and promotes the recruitment of inflammatory cells to the joints</strong>, leading to <strong>synovial inflammation and destruction of cartilage and bone</strong>. Drugs that <strong>target TNF-&alpha;,</strong> such as <strong>infliximab and adalimumab, </strong>have been shown to be effective in the treatment of<strong> psoriatic arthritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TNF-&alpha; </strong>is indeed a key <strong>pro-inflammatory cytokine in the pathogenesis of psoriatic arthritis. </strong>It promotes <strong>inflammation in the joints and skin</strong>, leading to the symptoms of <strong>arthritis and psoriasis</strong>. <strong>TNF-&alpha; inhibitors </strong>are a mainstay of treatment for <strong>moderate to severe cases, </strong>highlighting its critical role in the <strong>disease process</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;IL-6 is another <strong>pro-inflammatory cytokine </strong>involved in the <strong>immune response and inflammation</strong>. While it plays a role in the <strong>pathophysiology </strong>of various arthritic conditions, including <strong>rheumatoid arthritis,</strong> <strong>TNF-&alpha; is more specifically targeted in the treatment of psoriatic arthritis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;IL-1&beta; is a<strong> pro-inflammatory cytokine</strong> that contributes to<strong> inflammation and cellular damage </strong>in many <strong>autoimmune</strong> <strong>diseases. </strong>Like<strong> TNF-&alpha; and IL-6</strong>, it is involved in the <strong>inflammatory cascade</strong> but is not as prominent a target in psoriatic arthritis as TNF-&alpha;.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IL-10</strong> is an <strong>anti-inflammatory cytokine </strong>that helps to regulate the <strong>immune response and dampen inflammation</strong>. It&#39;s typically not the target in psoriatic arthritis treatment strategies but rather part of the <strong>body&#39;s natural mechanism to control excessive inflammation</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TNF-&alpha; i</strong>s critically involved in the<strong> inflammatory processes of psoriatic arthritis </strong>and is a primary target for <strong>therapeutic intervention</strong>. <strong>Biologic agents</strong> that inhibit TNF-&alpha;, such as<strong> infliximab</strong>, have been effective in <strong>reducing the inflammation and joint damage associated with psoriatic arthritis</strong>. </span></span></span></p>",
      "correct_choice_id": 56501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14171,
      "choices": [
        {
          "id": 56645,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transplant rejection phenomenon </span></span></span></p>"
        },
        {
          "id": 56646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Governing susceptibility to autoimmune diseases </span></span></span></p>"
        },
        {
          "id": 56647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immune surveillance </span></span></span></p>"
        },
        {
          "id": 56648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antigen presentation and elimination </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of human leukocyte antigen (HLA) genetics, the HLA class III region has been implicated in which of the following processes?</span></span></span></p>",
      "unique_key": "Q6843193",
      "question_audio": null,
      "question_video": null,
      "map_id": 31851,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Governing susceptibility to autoimmune diseases </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Governing Susceptibility to Autoimmune Diseases:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> HLA class III region </strong>contains genes for<strong> complement components</strong>, such as <strong>C2 and C4</strong>, which are involved in the <strong>classical complement pathway</strong>. Deficiencies in these components have been linked with an <strong>increased susceptibility to autoimmune diseases</strong>, such as <strong>systemic lupus erythematosus (SLE).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Transplant Rejection Phenomenon:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Transplant rejection typically involves <strong>HLA class I and class II regions, </strong>as these regions encode for molecules directly involved in <strong>antigen presentation </strong>that can be recognized by the<strong> recipient&#39;s immune system</strong>, leading to <strong>rejection.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Immune Surveillance:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While immune surveillance is an essential function of the <strong>immune system </strong>in identifying and d<strong>estroying pathogens and abnormal cells</strong>, it is more closely associated with <strong>HLA class I and II molecules&#39; </strong>ability to present antigens.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Antigen Presentation and Elimination:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Antigen presentation and elimination are directly related to <strong>HLA class I and class II molecules</strong>, which present <strong>peptides to T cells</strong>. The <strong>HLA class III region is not primarily involved in antigen presentation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>HLA class III region </strong>is involved in the regulation of <strong>susceptibility to autoimmune diseases </strong>due to its role in<strong> encoding early components of the complement system.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: 10<sup>th</sup>/ 215) </span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></strong></span></span></p>",
      "correct_choice_id": 56646,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14141,
      "choices": [
        {
          "id": 56525,
          "text": "<p><span style=\"font-size:12pt;\">1:1</span></p>"
        },
        {
          "id": 56526,
          "text": "<p><span style=\"font-size:12pt;\">1:3</span></p>"
        },
        {
          "id": 56527,
          "text": "<p>3:1</p>"
        },
        {
          "id": 56528,
          "text": "<p><span style=\"font-size:12pt;\">1:4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 30-year-old man participates in a clinical study examining immune function. He is in excellent health with no history of immune-related disorders. A complete blood count with differential and a lymphocyte subset panel are performed. Which of the following is the expected normal ratio of T cells to B cells in this individual's peripheral blood?</span></p>",
      "unique_key": "Q8364436",
      "question_audio": null,
      "question_video": null,
      "map_id": 31838,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 3:1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the peripheral blood of a healthy individual,<strong> T cells are 6070% and B cells are 1020% of the lymphocytes. </strong>So, the best answer with the given options is <strong>3:1.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1:1</strong>: Would suggest an abnormally high B cell count or low T cell count</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 1:3 and D. 1:4:</strong> Suggest a B cell-predominant profile, which is not normal for healthy adults</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The typical ratio of<strong> T cells to B cells in the peripheral blood </strong>of a healthy individual is approximately <strong>3:1</strong>, reflecting the <strong>predominance of T cells, which comprise 6070% of lymphocytes, while B cells make up about 1020%.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical Relevance:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A 3:1 T:B cell ratio is considered physiological.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Altered ratios can be seen in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Immunodeficiencies</span></li><li><span style=\"font-size:12.0pt;\">Leukemias/lymphomas</span></li><li><span style=\"font-size:12.0pt;\">Autoimmune diseases</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10th/e p195 )</strong></span></p>",
      "correct_choice_id": 56527,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14142,
      "choices": [
        {
          "id": 56529,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD25 </span></span></span></p>"
        },
        {
          "id": 56530,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD3 </span></span></span></p>"
        },
        {
          "id": 56531,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD94 </span></span></span></p>"
        },
        {
          "id": 56532,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD68 </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old female with a history of recurrent viral infections is referred to an immunologist for evaluation. Laboratory studies are ordered to assess her immune cell populations, including a flow cytometry panel to identify various lymphocyte subsets based on surface markers. Which of the following cell surface markers is most commonly associated with natural killer (NK) cells?</span></span></span></p>",
      "unique_key": "Q7941276",
      "question_audio": null,
      "question_video": null,
      "map_id": 31839,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) CD94 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD94:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD94 is part of a family of<strong> C-type lectin receptors </strong>that are predominantly expressed on <strong>NK cells and a subset of CD8+ T cells. </strong>It forms a complex with <strong>NKG2A/B/C </strong>to interact with<strong> non-classical MHC class I molecules like HLA-E.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: CD25:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD25 is the<strong> alpha chain </strong>of the <strong>IL-2 receptor</strong>, which is expressed on activated <strong>T and B cells, and some NK cells. </strong>It&#39;s <strong>not specific for NK cells</strong>, as it is also present on regulatory <strong>T cells (Tregs).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: CD3:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD3 is a complex of proteins associated with the <strong>T-cell receptor (TCR) on T-lymphocytes. </strong>It is<strong> not found on NK cells, </strong>which do not express TCRs.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: CD68:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD68 is a marker associated with <strong>macrophages </strong>and is <strong>not expressed on NK cells</strong>. It is typically used to identify cells of the <strong>myeloid lineage</strong>, particularly in the context of<strong> tissue-resident macrophages.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>surface marker CD94 </strong>is predominantly expressed on <strong>natural killer (NK) cells and a subset of CD8+ T cells </strong>and is involved in the recognition of<strong> non-classical MHC class I molecules</strong></span></span></span></p>",
      "correct_choice_id": 56531,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14144,
      "choices": [
        {
          "id": 56537,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Helper T cells</span></span></span></p>"
        },
        {
          "id": 56538,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Natural killer cells</span></span></span></p>"
        },
        {
          "id": 56539,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suppressor T cells</span></span></span></p>"
        },
        {
          "id": 56540,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytotoxic T cells</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC-I will present antigen to:</span></span></span></p>",
      "unique_key": "Q4171634",
      "question_audio": null,
      "question_video": null,
      "map_id": 31841,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Cytotoxic T cells </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&bull; <strong>MHC I</strong> presents antigen to <strong>CD8 T cell</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&bull;<strong> MHC II </strong>presents antigen to <strong>CD4 T cell</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytotoxic T cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cytotoxic T cells <strong>(CD8+ T cells) </strong>are directly activated by <strong>antigens presented on MHC class I molecules. </strong>These cells are important for the elimination of<strong> virus-infected cells and tumor cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Helper T cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Helper T cells <strong>(CD4+ T cells) </strong>are primarily activated by <strong>antigens presented on MHC class II molecules</strong>. They are crucial for the <strong>orchestration of the immune response,</strong> including the activation of<strong> B cells and other T cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Natural killer cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Natural killer (NK) cells are part of the<strong> innate immune system</strong> and <strong>do not require antigen presentation</strong> by <strong>MHC molecules for activation</strong>. Instead, they <strong>monitor </strong>the level of<strong> MHC class I expression </strong>and can be<strong> activated </strong>when they detect <strong>reduced MHC I levels</strong>, which is often indicative of<strong> viral infection or malignancy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Suppressor T cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Suppression or regulatory T cells (Tregs), often referred to in the context of <strong>CD4+ T cells </strong>with suppressive function,<strong> do not directly interact with MHC class I. </strong>They regulate the immune response to maintain tolerance to <strong>self-antigens and prevent autoimmune disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC class I molecules present antigens to cytotoxic T cells (CD8+ T cells) whereas MHC class II molecules present antigens to CD4+ T cells. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p198)</span></strong></span></span></p>",
      "correct_choice_id": 56540,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14148,
      "choices": [
        {
          "id": 56553,
          "text": "<p><span style=\"font-size:12pt;\">Memory</span></p>"
        },
        {
          "id": 56554,
          "text": "<p><span style=\"font-size:12pt;\">Immunoglobulin production</span></p>"
        },
        {
          "id": 56555,
          "text": "<p><span style=\"font-size:12pt;\">Activation of macrophages</span></p>"
        },
        {
          "id": 56556,
          "text": "<p><span style=\"font-size:12pt;\">Cytotoxicity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following require normal functioning of CD4 molecule except:</span></p>",
      "unique_key": "Q9982863",
      "question_audio": null,
      "question_video": null,
      "map_id": 31844,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Cytotoxicity</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">CD4+ T cells are generally not cytotoxic; this function is characteristic of CD8+ cytotoxic T cells which kill virus-infected cells and tumor cells.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Memory: CD4+ T cells </strong>differentiate into <strong>memory T cells </strong>following <strong>antigen exposure</strong>, which provides <strong>long-term immunity by remembering the antigen for faster response upon re-exposure</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Immunoglobulin Production:</strong> CD4+ T cells, particularly the Th2 subset, are critical for B cell help, leading to B cell proliferation, differentiation, and subsequent immunoglobulin production.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Activation of Macrophages:</strong> <strong>Th1 subset of CD4+ T cells </strong>can activate <strong>macrophages </strong>by secreting cytokines such as<strong> IFN- and TNF-</strong>, enhancing their <strong>microbicidal activity</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>CD4+ T cells </strong>are pivotal for <strong>immune responses</strong>, including <strong>memory formation and macrophage activation,</strong> and are responsible for formation of different classes of antibodies (isotype switching in antibodies)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 190-191)</strong></span></p>",
      "correct_choice_id": 56556,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14150,
      "choices": [
        {
          "id": 56561,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RA </span></span></span></p>"
        },
        {
          "id": 56562,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RB </span></span></span></p>"
        },
        {
          "id": 56563,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RC </span></span></span></p>"
        },
        {
          "id": 56564,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RO</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In evaluating a patient&#39;s immune status, particularly the cellular immunity involving T lymphocytes, which surface marker is characteristic of memory T cells as opposed to naive T cells?</span></span></span></p>",
      "unique_key": "Q7123845",
      "question_audio": null,
      "question_video": null,
      "map_id": 31846,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) CD45RO </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RO:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD45RO is the marker associated with <strong>memory T cells</strong>. These cells have previously <strong>encountered antigen </strong>and can quickly expand upon<strong> re-exposure to that specific antigen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: CD45RA:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD45RA is a marker typically found on <strong>naive T cells</strong>. These cells have <strong>not yet </strong>encountered their <strong>specific antigen </strong>and are<strong> not yet differentiated into effector or memory cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: CD45RB:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD45RB is expressed on <strong>all leukocytes </strong>and is <strong>not specific to either naive or memory T cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: CD45RC:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD45RC&#39;s expression can vary but is not specifically associated with<strong> memory T cells</strong>. It is another<strong> isoform of the CD45 molecule</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>CD45RO </strong>is a cell surface marker characteristic of <strong>memory T cells</strong>, which play a crucial role in the <strong>immune system&#39;s ability </strong>to respond more<strong> rapidly and effectively </strong>upon <strong>re-exposure to pathogens.</strong></span></span></p>",
      "correct_choice_id": 56564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14203,
      "choices": [
        {
          "id": 56773,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-a, 4-b </span></span></p>"
        },
        {
          "id": 56774,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-d, 3-a, 4-c </span></span></span></p>"
        },
        {
          "id": 56775,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-d, 3-b, 4-a </span></span></span></p>"
        },
        {
          "id": 56776,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-a, 3-b, 4-c </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following complement deficiencies with the disorders given:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/01/screenshot-2024-06-01-104551.JPG\" style=\"height:225px; width:700px\" /></span></span></span></p>",
      "unique_key": "Q6799999",
      "question_audio": null,
      "question_video": null,
      "map_id": 31854,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1-b, 2-d, 3-a, 4-c </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/01/screenshot-2024-06-01-122206.JPG\" style=\"height:217px; width:700px\" /></p>",
      "correct_choice_id": 56774,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14211,
      "choices": [
        {
          "id": 56805,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mature dendritic cell </span></span></span></p>"
        },
        {
          "id": 56806,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular dendritic cell </span></span></span></p>"
        },
        {
          "id": 56807,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Macrophages </span></span></span></p>"
        },
        {
          "id": 56808,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B cell </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following cells would you identify as the most potent stimulator of na&iuml;ve T cells?</span></span></span></p>",
      "unique_key": "Q1555387",
      "question_audio": null,
      "question_video": null,
      "map_id": 31831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Mature dendritic cell </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mature dendritic cell:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Mature dendritic cells are the most potent <strong>APCs due to their high expression of MHC class II molecules </strong>and costimulatory molecules necessary for <strong>na&iuml;ve T cell activation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Follicular dendritic cell:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Follicular dendritic cells, primarily found in the<strong> lymph nodes</strong>, do not express MHC class II molecules; they<strong> present antigens to B cells in humoral immune responses, </strong>not na&iuml;ve T cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Macrophages:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While macrophages can serve as<strong> APCs and activate T cells</strong>, they are <strong>less potent</strong> than <strong>dendritic cells </strong>and typically engage in <strong>phagocytosis and antigen presentation during inflammation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: B cell:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> B cells can present antigens to <strong>helper T cells</strong>, particularly in the context of <strong>humoral immune responses, </strong>but they are not the <strong>most potent APCs </strong>for initiating responses in na&iuml;ve T cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most <strong>potent stimulator </strong>of a <strong>na&iuml;ve T cell </strong>is the <strong>mature dendritic cell </strong>due to its<strong> high expression of MHC molecules </strong>and the ability to provide the necessary <strong>costimulatory signals </strong>required for<strong> T cell activation. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 191) </span></em></strong></span></span></p>",
      "correct_choice_id": 56805,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14213,
      "choices": [
        {
          "id": 56813,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perforin and granzyme mediated apoptosis </span></span></span></p>"
        },
        {
          "id": 56814,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FADD ligand apoptosis </span></span></span></p>"
        },
        {
          "id": 56815,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transcription of nuclear factor mediated by NF-&kappa;</span><em><span style=\"font-family:Symbol\">b</span></em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> which recruits cytokines </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></span></span></p>"
        },
        {
          "id": 56816,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclin </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toll like receptors, recognize bacterial products and stimulates immune response by: </span></span></span></p>",
      "unique_key": "Q7751785",
      "question_audio": null,
      "question_video": null,
      "map_id": 31832,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Transcription of nuclear factor mediated by NF-&kappa;&beta; which recruits cytokines</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;</strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transcription </strong>of nuclear factor mediated by <strong>NF-&kappa;&beta; </strong>which <strong>recruits cytokines </strong>is a pivotal response in th<strong>e innate immune system</strong>. NF-&kappa;&beta; is a<strong> transcription factor </strong>that is activated by <strong>Toll-like receptors </strong>upon recognition of<strong> pathogen-associated molecular patterns</strong>, leading to the production of <strong>pro-inflammatory cytokines</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Perforin and granzyme-mediated apoptosis</strong> is a mechanism utilized by <strong>cytotoxic T cells and natural killer cells</strong> to induce <strong>cell death in infected or abnormal cells. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FADD ligand apoptosis </strong>involves the<strong> Fas-associated death domain protein</strong>, part of the <strong>extrinsic pathway for apoptosis, </strong>typically triggered by the<strong> Fas ligand </strong>binding to its receptor. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Cyclin proteins</strong> are involved in the regulation of the <strong>cell cycle </strong>and <strong>do not </strong>have a direct role in <strong>immune responses or signaling</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Toll-like receptors </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are <strong>membrane proteins </strong>that recognize a variety of <strong><em>microbe-derived molecules </em></strong>and stimulate <strong>innate immune </strong>responses against the<strong> microbes</strong>. These derive there name due to<strong> homology to a <em>Drosophila </em>protein </strong>called &lsquo;Toll&rsquo;. The <strong>Toll-like receptors </strong>are expressed on many <strong>immune cells of the body. </strong><em><strong>Signaling by Toll-like receptors </strong>result in the<strong> activation of transcription factors notably NF-&kappa;</strong></em></span><strong><em><span style=\"font-family:Symbol\">b</span></em><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></em></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Robbins 10<sup>th</sup>/ 187 </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
      "correct_choice_id": 56815,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14214,
      "choices": [
        {
          "id": 56817,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-2 </span></span></span></p>"
        },
        {
          "id": 56818,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-4 </span></span></span></p>"
        },
        {
          "id": 56819,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-5 </span></span></span></p>"
        },
        {
          "id": 56820,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-10 </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of a cell-mediated immune response, a 30-year-old patient with chronic granulomatous disease is being evaluated for cytokine profiles to assess T-helper cell function. Which cytokine is predominantly expected to be produced by T-helper type 1 (TH1) cells in this patient?</span></span></span></p>",
      "unique_key": "Q4294292",
      "question_audio": null,
      "question_video": null,
      "map_id": 31833,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) IL-2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-helper cells </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">can be divided in <strong>three distinct type</strong>s on the basis of <strong>different cytokines they produce. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-helper &ndash; 1 (TH1) secretes: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IL-2 and interferon y</strong>, important for<strong> type IV hypersensitivity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-helper &ndash; 2 (TH1) secretes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IL-4, IL-5,</strong> important for type I hypersensitivity reaction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TH 17 cells: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secretes: <strong>IL-17, IL-22</strong>, these cells defend against <strong>extracellular bacteria and fungi.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IL-2 </strong>is a cytokine produced by<strong> TH1 cells </strong>and is crucial for the <strong>growth, proliferation, and differentiation of T cells.</strong> It is also involved in the <strong>activation of natural killer cells </strong>and is essential for<strong> type IV hypersensitivity reactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>IL-4</strong> is characteristic of<strong> TH2 cells</strong> and is vital in <strong>humoral immunity. </strong>It promotes the differentiation of<strong> B cells into plasma cells </strong>and class switching to<strong> IgE</strong>, which is important for<strong> type I hypersensitivity reactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IL-5 </strong>is another cytokine produced by <strong>TH2 cells</strong>, promoting <strong>growth and differentiation of B cells</strong>. It also stimulates the <strong>production and activation of eosinophils</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IL-10 </strong>is an <strong>anti-inflammatory cytokine </strong>that can be produced by <strong>various cells, including some TH2 cells, and regulatory T cells</strong>. It is known to inhibit the synthesis of <strong>pro-inflammatory cytokines and can downregulate TH1 responses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IL-2</strong>, is this <strong>cytokine </strong>that is primarily produced by <strong>TH1 cells </strong>and is integral to <strong>cell-mediated immune responses</strong>, particularly in the defense against<strong> intracellular pathogens </strong>and in mediating<strong> type IV hypersensitivity reactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 198) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
      "correct_choice_id": 56817,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14119,
      "choices": [
        {
          "id": 56437,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis </span></span></span></p>"
        },
        {
          "id": 56438,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis </span></span></span></p>"
        },
        {
          "id": 56439,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histoplasmosis </span></span></span></p>"
        },
        {
          "id": 56440,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hodgkin&#39;s Lymphoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male presents with erythema nodosum and polyarthralgia. Chest x-ray reveals bilateral hilar lymphadenopathy. Biopsy of the lymph nodes shows non-caseating granulomas. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q1960663",
      "question_audio": null,
      "question_video": null,
      "map_id": 31834,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Sarcoidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sarcoidosis</strong> is a <strong>systemic inflammatory disease </strong>that can affect<strong> multiple organs, including the lungs, lymph nodes, skin, and joints.</strong> <strong>Erythema nodosum and polyarthralgia </strong>are common <strong>extra-pulmonary manifestations of sarcoidosis</strong>. The presence of <strong>non-caseating granulomas in the lymph nodes and bilateral hilar lymphadenopathy </strong>supports the diagnosis of sarcoidosis in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>multisystem inflammatory disease </strong>characterized by <strong>non-caseating granulomas in multiple organs, </strong>including the <strong>lymph nodes. Bilateral hilar lymphadenopathy and erythema nodosum </strong>are classic presentations, along with<strong> pulmonary involvement and arthralgia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tuberculosis,&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">caused by <strong>Mycobacterium tuberculosis</strong>, typically presents with<strong> caseating granulomas</strong>, not non-caseating. It can cause similar symptoms and chest radiograph findings, but the<strong> granulomas in tuberculosis usually exhibit central necrosis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Histoplasmosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>fungal infection </strong>that can cause<strong> granulomatous inflammation</strong>. It often presents with symptoms similar to<strong> tuberculosis </strong>and can affect the <strong>lungs and lymph nodes</strong>. However, it is more commonly associated with <strong>caseating granulomas and typically occurs in endemic areas</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hodgkin&#39;s lymphoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a type of lymphoma that can present with <strong>lymphadenopathy</strong>; however, it is diagnosed by the presence of <strong>Reed-Sternberg cells in the lymph nodes</strong>, not non-caseating granulomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This diagnosis of<strong> sarcoidosis is supported </strong>by the clinical presentation of<strong> erythema nodosum, polyarthralgia, bilateral hilar lymphadenopathy, and biopsy findings of non-caseating granulomas. </strong></span></span></span></p>",
      "correct_choice_id": 56438,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14121,
      "choices": [
        {
          "id": 56445,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immune system dysfunction </span></span></span></p>"
        },
        {
          "id": 56446,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genetic defect in the NADPH oxidase enzyme </span></span></span></p>"
        },
        {
          "id": 56447,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic exposure to environmental toxins</span></span></span></p>"
        },
        {
          "id": 56448,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic viral infection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old female presents with a painful and tender nodule on her lower leg. She reports a history of travel to an endemic area for leprosy and was treated successfully. A biopsy of the lesion shows a granulomatous inflammation with giant cells. What is the pathophysiology underlying this patient&#39;s condition?</span></span></p>",
      "unique_key": "Q9212738",
      "question_audio": null,
      "question_video": null,
      "map_id": 31835,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Immune system dysfunction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Granulomatous inflammation </strong>can occur as a result of<strong> immune system dysfunction</strong>, particularly in response to intracellular pathogens such as <strong>mycobacteria and leprosy</strong>. In these conditions, the <strong>host immune response leads to the formation of granulomas, </strong>which are aggregates of <strong>activated macrophages and other immune cells </strong>that wall off the infection. The giant cells present in these granulomas are formed by the <strong>fusion of epithelioid cells</strong>, which are activated macrophages that have taken up and processed the antigen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leprosy </strong>is caused by the bacterium <strong>Mycobacterium leprae</strong>, which leads to an<strong> immune response </strong>that can result in<strong> granuloma formation</strong>. The condition represents an i<strong>mmune system response </strong>trying to contain the<strong> pathogen</strong>, which may be<strong> dysfunctional or overactive, leading to tissue damage and the formation of nodules</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Enzyme A genetic defect in NADPH oxidase </strong>results in<strong> chronic granulomatous disease</strong>, a condition where <strong>phagocytes can ingest </strong>but<strong> cannot kill certain bacteria and fungi due to a lack of reactive oxygen </strong>species production. This is different from the immune response to leprosy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Environmental toxins </strong>can lead to various forms of <strong>inflammation and tissue damage</strong>, but they are not typically associated with granulomatous inflammation due to an infectious disease like leprosy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Chronic viral infections </strong>can lead to persistent<strong> immune responses </strong>and sometimes<strong> granulomatous inflammation</strong>; however, <strong>leprosy is a bacterial infection</strong>, not viral.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of<strong> leprosy, granulomatous inflammation </strong>is a result of the body&#39;s immune response to the<strong> intracellular pathogen, Mycobacterium leprae</strong>. The formation of <strong>granulomas</strong>, often containing <strong>giant cells</strong>, is a way the <strong>immune system</strong> attempts to contain the <strong>pathogen. </strong></span></span></span></p>",
      "correct_choice_id": 56445,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16854,
      "choices": [
        {
          "id": 67376,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical carcinoma</span></span></span></p>"
        },
        {
          "id": 67377,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral carcinoma</span></span></span></p>"
        },
        {
          "id": 67378,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laryngeal papillomatosis.</span></span></span></p>"
        },
        {
          "id": 67379,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anorectal carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are caused by lethal strains of HPV, except:</span></span></p>",
      "unique_key": "Q1096283",
      "question_audio": null,
      "question_video": null,
      "map_id": 31848,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Laryngeal papillomatosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laryngeal papillomatosis </strong>is commonly caused by <strong>HPV types 6 and 11</strong>, which are considered <strong>low-risk types</strong>. While it can <strong>cause </strong>significant <strong>morbidity </strong>due to <strong>recurrent benign papillomas </strong>in the <strong>larynx</strong>, it is not typically associated with the development of cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Cervical carcinoma:</strong> <strong>Persistent infection </strong>with these <strong>high-risk HPV types </strong>especially <strong>HPV 16, 18, 31 and 33 </strong>, can lead to the <strong>progression of cervical dysplasia </strong>to invasive carcinoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Oral carcinoma:</strong> <strong>HPV infection</strong>, especially with <strong>types 16 and 18</strong>, has been <strong>linked to the development of oral </strong>and <strong>oropharyngeal cancers</strong>, particularly in the tonsillar and base of the tongue areas.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Anorectal carcinoma:</strong> <strong>High-risk HPV types</strong>, including <strong>16 and 18</strong>, are implicated in the <strong>development of anal </strong>and <strong>anorectal carcinomas</strong>. These cancers are more prevalent in individuals with persistent HPV infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laryngeal papillomatosis </strong>is typically caused by the <strong>low-risk human papillomavirus </strong>(HPV) <strong>types 6 and 11</strong>, which are <strong>not commonly associated with malignancy</strong>. In contrast, high-risk HPV types, particularly 16 and 18, are associated with an increased risk of developing cancers such as cervical carcinoma, oral carcinoma, and anorectal carcinoma.</span></span></span></p>",
      "correct_choice_id": 67378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16855,
      "choices": [
        {
          "id": 67380,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">E6 </span></span></span></p>"
        },
        {
          "id": 67381,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">E7</span></span></span></p>"
        },
        {
          "id": 67382,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">LMP1 </span></span></span></p>"
        },
        {
          "id": 67383,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tax</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female presents with a history of persistent genital warts. Upon further investigation, it is found that the Human Papillomavirus (HPV) responsible for her condition produces a protein that interacts with the Retinoblastoma (Rb) tumor suppressor protein, leading to its degradation. Which of the following HPV proteins is involved in this process?</span></span></p>",
      "unique_key": "Q4607619",
      "question_audio": null,
      "question_video": null,
      "map_id": 31850,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) E7 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>E7 protein </strong>produced by <strong>Human Papillomavirus </strong>(HPV) interacts with the <strong>Retinoblastoma </strong>(Rb) <strong>tumor suppressor protein</strong>, leading to its <strong>degradation or inactivation</strong>. This <strong>interaction </strong>disrupts the <strong>regulation of cell cycle progression </strong>and <strong>promotes cell proliferation</strong>, contributing to the oncogenic potential of HPV.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. E6&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>protein </strong>of <strong>HPV </strong>interacts with <strong>cellular proteins</strong>, including <strong>p53</strong>, leading to its <strong>degradation</strong>, which can disrupt cell cycle control and apoptosis regulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. LMP1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Latent Membrane Protein 1 </strong>is a <strong>protein </strong>produced by the <strong>Epstein-Barr virus</strong>. It plays a role in oncogenesis by activating signaling pathways involved in cell proliferation and survival.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tax&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>protein </strong>produced by the <strong>Human T-cell Leukemia Virus type 1 </strong>(HTLV-1), not HPV. Tax protein is known to interact with various cellular proteins and pathways, promoting cell proliferation and inhibiting apoptosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>HPV E7 protein </strong>has a <strong>role in promoting cellular proliferation </strong>and <strong>potential oncogenesis </strong>through <strong>interaction </strong>with the <strong>retinoblastoma </strong>(Rb) <strong>tumor suppressor protein</strong>, leading to its <strong>degradation. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p324</span></strong></span></span></p>",
      "correct_choice_id": 67381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}